Othman, L., Koskina, L., Huerta, N., & Rao, S. J. (2025). The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy. Heart Failure Reviews, 30(2), 453-467. https://doi.org/10.1007/s10741-024-10476-w
Chicago-referens (17:e uppl.)Othman, Leen, Lida Koskina, Nicholas Huerta, och Shiavax J. Rao. "The Clinical Utility of Cardiac Myosin Inhibitors for the Management of Hypertrophic Cardiomyopathy." Heart Failure Reviews 30, no. 2 (2025): 453-467. https://doi.org/10.1007/s10741-024-10476-w.
MLA-referens (9:e uppl.)Othman, Leen, et al. "The Clinical Utility of Cardiac Myosin Inhibitors for the Management of Hypertrophic Cardiomyopathy." Heart Failure Reviews, vol. 30, no. 2, 2025, pp. 453-467, https://doi.org/10.1007/s10741-024-10476-w.
